(DX) Dynex Capital - Overview
Sector: Real Estate | Industry: REIT - Mortgage | Exchange: NYSE (USA) | Market Cap: 2.734m USD | Total Return: 38.8% in 12m
Industry Rotation: -1.7
Avg Turnover: 68.3M USD
Peers RS (IBD): 52.1
EPS Trend: 34.0%
Qual. Beats: 0
Rev. Trend: 57.5%
Qual. Beats: 3
Warnings
Share dilution 92.4% YoY - potential capital distress
Tailwinds
No distinct edge detected
Dynex Capital Inc. (NYSE: DX) is a mortgage REIT that primarily invests in U.S. agency and non-agency mortgage-backed securities, including residential MBS, commercial MBS (CMBS), and interest-only CMBS. The agency securities are backed by guarantees from Fannie Mae, Freddie Mac, or other government-sponsored entities, while the non-agency holdings carry no such guarantee. As a REIT, Dynex must distribute at least 90 % of its taxable income to shareholders to retain its tax-exempt status.
As of the most recent quarter (Q1 2024), Dynex reported a dividend yield of roughly 9.2 % and a distribution per share of $0.91, supported by a net asset value (NAV) of $9.45 per share. The portfolio’s weighted-average coupon sits near 3.6 %, and the company’s debt-to-equity ratio remains modest at 1.2 ×, reflecting a balanced leverage profile amid a tightening credit environment.
Key drivers for Dynex’s performance include Federal Reserve policy-higher policy rates compress MBS spreads and pressure coupon yields-and the broader U.S. housing market, where declining home-price appreciation can affect the supply of new agency securities. Additionally, the spread between agency and non-agency MBS continues to widen, offering potential yield-enhancement opportunities for REITs that can manage credit risk effectively.
For a deeper dive, you might explore ValueRay’s analytics on DX.
- Interest rate fluctuations impact MBS portfolio value
- Agency MBS spreads affect net interest margin
- Non-Agency MBS credit performance drives income
- Regulatory changes influence REIT tax status
- Hedging effectiveness mitigates interest rate risk
| Net Income: 319.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.52 > 1.0 |
| NWC/Revenue: -2.59k% < 20% (prev -1.88k%; Δ -710.1% < -1%) |
| CFO/TA 0.01 > 3% & CFO 120.8m > Net Income 319.1m |
| Net Debt (12.98b) to EBITDA (738.2m): 17.59 < 3 |
| Current Ratio: 0.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.2m) vs 12m ago 92.42% < -2% |
| Gross Margin: 51.02% > 18% (prev 0.94%; Δ 5.01k% > 0.5%) |
| Asset Turnover: 4.18% > 50% (prev 3.89%; Δ 0.29% > 0%) |
| Interest Coverage Ratio: 0.18 > 6 (EBITDA TTM 738.2m / Interest Expense TTM 419.2m) |
| A: -0.80 (Total Current Assets 1.03b - Total Current Liabilities 14.85b) / Total Assets 17.34b |
| B: -0.03 (Retained Earnings -441.9m / Total Assets 17.34b) |
| C: 0.01 (EBIT TTM 74.4m / Avg Total Assets 12.76b) |
| D: -0.04 (Book Value of Equity -567.2m / Total Liabilities 14.88b) |
| Altman-Z'' Score: -5.31 = D |
Over the past week, the price has changed by +2.09%, over one month by -1.81%, over three months by -2.67% and over the past year by +38.78%.
- StrongBuy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 15.1 | 14.7% |
P/E Forward = 6.7069
P/S = 7.3466
P/B = 1.1498
P/EG = 0.7056
Revenue TTM = 533.5m USD
EBIT TTM = 74.4m USD
EBITDA TTM = 738.2m USD
Long Term Debt = 8.37m USD (from longTermDebt, last quarter)
Short Term Debt = 13.91b USD (from shortTermDebt, last quarter)
Debt = 13.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.98b USD (from netDebt column, last quarter)
Enterprise Value = 16.12b USD (2.73b + Debt 13.91b - CCE 531.0m)
Interest Coverage Ratio = 0.18 (Ebit TTM 74.4m / Interest Expense TTM 419.2m)
EV/FCF = 133.4x (Enterprise Value 16.12b / FCF TTM 120.8m)
FCF Yield = 0.75% (FCF TTM 120.8m / Enterprise Value 16.12b)
FCF Margin = 22.65% (FCF TTM 120.8m / Revenue TTM 533.5m)
Net Margin = 59.80% (Net Income TTM 319.1m / Revenue TTM 533.5m)
Gross Margin = 51.02% ((Revenue TTM 533.5m - Cost of Revenue TTM 261.3m) / Revenue TTM)
Gross Margin QoQ = 28.66% (prev 20.45%)
Tobins Q-Ratio = 0.93 (Enterprise Value 16.12b / Total Assets 17.34b)
Interest Expense / Debt = 0.96% (Interest Expense 133.6m / Debt 13.91b)
Taxrate = 21.0% (US default 21%)
NOPAT = 58.7m (EBIT 74.4m * (1 - 21.00%))
Current Ratio = 0.07 (Total Current Assets 1.03b / Total Current Liabilities 14.85b)
Debt / Equity = 5.65 (Debt 13.91b / totalStockholderEquity, last quarter 2.46b)
Debt / EBITDA = 17.59 (Net Debt 12.98b / EBITDA 738.2m)
Debt / FCF = 107.5 (Net Debt 12.98b / FCF TTM 120.8m)
Total Stockholder Equity = 1.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.50% (Net Income 319.1m / Total Assets 17.34b)
RoE = 17.19% (Net Income TTM 319.1m / Total Stockholder Equity 1.86b)
RoCE = 3.99% (EBIT 74.4m / Capital Employed (Equity 1.86b + L.T.Debt 8.37m))
RoIC = 0.37% (NOPAT 58.7m / Invested Capital 15.84b)
WACC = 1.95% (E(2.73b)/V(16.65b) * Re(7.99%) + D(13.91b)/V(16.65b) * Rd(0.96%) * (1-Tc(0.21)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 65.64%
[DCF] Terminal Value 87.15% ; FCFF base≈78.2m ; Y1≈85.3m ; Y5≈107.4m
[DCF] Fair Price = N/A (negative equity: EV 3.16b - Net Debt 12.98b = -9.82b; debt exceeds intrinsic value)
EPS Correlation: 33.98 | EPS CAGR: -19.28% | SUE: -0.89 | # QB: 0
Revenue Correlation: 57.50 | Revenue CAGR: -7.55% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.28 | Chg7d=+0.005 | Chg30d=+0.005 | Revisions Net=-2 | Analysts=3
EPS current Year (2026-12-31): EPS=1.18 | Chg7d=+0.010 | Chg30d=+0.010 | Revisions Net=-2 | Growth EPS=+52.0% | Growth Revenue=+120.6%
EPS next Year (2027-12-31): EPS=1.38 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+17.2% | Growth Revenue=+24.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -10.7% (Discount Rate 8.0% - Earnings Yield 18.7%)
[Growth] Growth Spread = +246.4% (Analyst 235.7% - Implied -10.7%)